Cargando…

The Impact of Epigallocatechin Gallate and Coconut Oil Treatment on Cortisol Activity and Depression in Multiple Sclerosis Patients

(1) Background: Multiple sclerosis (MS) is pathogenically characterized by high oxidative stress and symptomatically by progressive muscle loss and increased body fat associated with the presence of depression. Epigallocatechin gallate (EGCG) (particularly present in green tea) and ketone bodies (in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Platero, Jose Luis, Cuerda-Ballester, María, Sancho-Cantus, David, Benlloch, María, Ceron, Jose Joaquin, Peres Rubio, Camila, García-Pardo, María Pilar, López-Rodríguez, María Mar, de la Rubia Ortí, Jose Enrique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073508/ https://www.ncbi.nlm.nih.gov/pubmed/33920655 http://dx.doi.org/10.3390/life11040353

Ejemplares similares

The Impact of Coconut Oil and Epigallocatechin Gallate on the Levels of IL-6, Anxiety and Disability in Multiple Sclerosis Patients
por: Platero, Jose Luis, et al.
Publicado: (2020)

Possible Role of Butyrylcholinesterase in Fat Loss and Decreases in Inflammatory Levels in Patients with Multiple Sclerosis after Treatment with Epigallocatechin Gallate and Coconut Oil: A Pilot Study
por: de la Rubia Ortí, Jose Enrique, et al.
Publicado: (2021)

Lipid Profile in Multiple Sclerosis: Functional Capacity and Therapeutic Potential of Its Regulation after Intervention with Epigallocatechin Gallate and Coconut Oil
por: de la Rubia Ortí, Jose Enrique, et al.
Publicado: (2023)

Possible Reduction of Cardiac Risk after Supplementation with Epigallocatechin Gallate and Increase of Ketone Bodies in the Blood in Patients with Multiple Sclerosis. A Pilot Study
por: Benlloch, María, et al.
Publicado: (2020)

Role of Haptoglobin as a Marker of Muscular Improvement in Patients with Multiple Sclerosis after Administration of Epigallocatechin Gallate and Increase of Beta-Hydroxybutyrate in the Blood: A Pilot Study
por: de la Rubia Ortí, Jose Enrique, et al.
Publicado: (2021)

Relationship of Motor Impairment with Cognitive and Emotional Alterations in Patients with Multiple Sclerosis
por: Cuerda-Ballester, María, et al.
Publicado: (2023)

Liposomal Epigallocatechin-3-Gallate for the Treatment of Intestinal Dysbiosis in Children with Autism Spectrum Disorder: A Comprehensive Review
por: de la Rubia Ortí, Jose Enrique, et al.
Publicado: (2023)

Satiating Effect of a Ketogenic Diet and Its Impact on Muscle Improvement and Oxidation State in Multiple Sclerosis Patients
por: Benlloch, María, et al.
Publicado: (2019)

Reply to “When Is a Ketogenic Diet Ketogenic? Comment on Satiating Effect of a Ketogenic Diet and Its Impact on Muscle Improvement and Oxidation State in Multiple Sclerosis Patients. Nutrients 2019, 11, 1156”
por: Benlloch, María, et al.
Publicado: (2019)

Vitamin B1 Intake in Multiple Sclerosis Patients and its Impact on Depression Presence: A Pilot Study
por: Ortí, Jose Enrique de la Rubia, et al.
Publicado: (2020)

Modification of Diurnal Cortisol Secretion in Women’s Professional Basketball. A Pilot Study
por: Sánchez, Irene, et al.
Publicado: (2021)

Metabolic and Functional Improvements in a Patient with Charcot-Marie-Tooth Disease Type 2 after EGCG Administration: A Case Report
por: Bustos, Antonio, et al.
Publicado: (2021)

Exploring the impact of ketogenic diet on multiple sclerosis: obesity, anxiety, depression, and the glutamate system
por: Ortí, Jose Enrique de la Rubia, et al.
Publicado: (2023)

Can Ketogenic Diet Improve Alzheimer's Disease? Association With Anxiety, Depression, and Glutamate System
por: de la Rubia Ortí, Jose Enrique, et al.
Publicado: (2021)

Zeolites with Divalent Ions as Carriers in the Delivery of Epigallocatechin Gallate
por: Sandomierski, Mariusz, et al.
Publicado: (2023)

Spectrophotometric assays for evaluation of Reactive Oxygen Species (ROS) in serum: general concepts and applications in dogs and humans
por: Rubio, Camila Peres, et al.
Publicado: (2021)

Therapeutic alternative of the ketogenic Mediterranean diet to improve mitochondrial activity in Amyotrophic Lateral Sclerosis (ALS): A Comprehensive Review
por: Caplliure‐Llopis, Jordi, et al.
Publicado: (2019)

Perceived stress and reference ranges of hair cortisol in healthy adolescents
por: Prado-Gascó, Vicente, et al.
Publicado: (2019)

Skin Protective Effect of Epigallocatechin Gallate
por: Kim, Eunji, et al.
Publicado: (2018)

Role of Epigallocatechin Gallate in Glucose, Lipid, and Protein Metabolism and L-Theanine in the Metabolism-Regulatory Effects of Epigallocatechin Gallate
por: Lin, Ling, et al.
Publicado: (2021)

Muscle Function Differences between Patients with Bulbar and Spinal Onset Amyotrophic Lateral Sclerosis. Does It Depend on Peripheral Glucose?
por: de la Rubia Ortí, Jose Enrique, et al.
Publicado: (2021)

Antitumor Effect of Epigallocatechin Gallate and Vincristine in Mice with L5178Y Lymphoma
por: Almaguer, Georgina, et al.
Publicado: (2023)

Nanocarriers Based on Gold Nanoparticles for Epigallocatechin Gallate Delivery in Cancer Cells
por: Cunha, Lídia, et al.
Publicado: (2022)

The Potential Role of Epigallocatechin-3-Gallate (EGCG) in Breast Cancer Treatment
por: Marín, Víctor, et al.
Publicado: (2023)

Epigallocatechin Gallate Nanodelivery Systems for Cancer Therapy
por: Granja, Andreia, et al.
Publicado: (2016)

Food-Grade Encapsulation Systems for (−)-Epigallocatechin Gallate
por: Shi, Meng, et al.
Publicado: (2018)

Therapeutic Potential of Epigallocatechin Gallate Nanodelivery Systems
por: Granja, Andreia, et al.
Publicado: (2017)

Effect of Epigallocatechin Gallate on Viability of Kudoa septempunctata
por: Shin, Sang Phil, et al.
Publicado: (2020)

Effects of epigallocatechin-3-gallate combined with ascorbic acid and glycerol on the stability and uric acid-lowering activity of epigallocatechin-3-gallate
por: Xie, Qianjin, et al.
Publicado: (2021)

Poor Bone Quality in Patients With Amyotrophic Lateral Sclerosis
por: Caplliure-Llopis, Jordi, et al.
Publicado: (2020)

Effect of the Mediterranean diet supplemented with nicotinamide riboside and pterostilbene and/or coconut oil on anthropometric variables in amyotrophic lateral sclerosis. A pilot study
por: Carrera-Juliá, Sandra, et al.
Publicado: (2023)

Bioavailability of Epigallocatechin Gallate Administered with Different Nutritional Strategies in Healthy Volunteers
por: Andreu Fernández, Vicente, et al.
Publicado: (2020)

Epigallocatechin-3-gallate and Epigallocatechin-3-O-(3-O-methyl)-gallate Enhance the Bonding Stability of an Etch-and-Rinse Adhesive to Dentin
por: Yu, Hao-Han, et al.
Publicado: (2017)

Effects of (-)-epigallocatechin gallate on RPE cell migration and adhesion
por: Chan, Chi-Ming, et al.
Publicado: (2010)

Broad inhibition of plasmodium falciparum cytoadherence by (+)-epigallocatechin gallate
por: Patil, Pradeep R, et al.
Publicado: (2011)

Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG)
por: Singh, Neha Atulkumar, et al.
Publicado: (2016)

Inhibitory Effects of (−)-Epigallocatechin-3-gallate on Esophageal Cancer
por: Wang, Liu-Xiang, et al.
Publicado: (2019)

The Effect of Ultrasound, Oxygen and Sunlight on the Stability of (−)-Epigallocatechin Gallate
por: Zeng, Jiajun, et al.
Publicado: (2018)

Melatonin and (−)-Epigallocatechin-3-Gallate: Partners in Fighting Cancer
por: Zhang, Lingyun, et al.
Publicado: (2019)

Anticancer effects and molecular mechanisms of epigallocatechin-3-gallate
por: Min, Kyoung-jin, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_dd3a3v66bcj017mrl1upqs5arm